HEMLIBRA
HEMLIBRA
Approved
DIN Number
02479621
Drug Class
Human
Market Date
Oct 19, 2018
Company
HC
Hoffmann-La Roche Limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02479621
AIG Number0160531001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
B02BX06 EMICIZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification20:28.16
Health Canada Classification
ACTIVE INGREDIENTS (1)
EMICIZUMABActive
Strength: 30 MG / 1 ML
Monograph: EMICIZUMAB